{"description":"Documents matching 'including fiscal their positions percent'","count":10000,"total_pages":50,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bterm%5D=including+fiscal+their+positions+percent&format=json&page=2","results":[{"title":"Over-the-Counter Monograph Drug Facility Fee Rates for Fiscal Year 2026","type":"Notice","abstract":"The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Over-the-Counter Monograph Drug User Fee Amendments (herein referred to as \"OMUFA II\"), authorizes the Food and Drug Administration (FDA, the Agency, or we) to assess and collect user fees from qualifying manufacturers of over-the-counter (OTC) monograph drugs and submitters of OTC monograph order requests (OMORs) for fiscal years 2026 through 2030. This notice publishes the OTC monograph drug facility (MDF) fee rates for fiscal year (FY) 2026.","document_number":"2026-05276","html_url":"https://www.federalregister.gov/documents/2026/03/18/2026-05276/over-the-counter-monograph-drug-facility-fee-rates-for-fiscal-year-2026","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-18/pdf/2026-05276.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-05276.pdf?1773751514","publication_date":"2026-03-18","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"shown in table 2), 43.5571 <span class=\"match\">percent</span> is the portion of costs other than PC&amp;B (100 <span class=\"match\">percent</span>−56.4429 <span class=\"match\">percent</span> = 43.5571 <span class=\"match\">percent</span>). The non-payroll adjustment is 4.3202 <span class=\"match\">percent</span> × 43.5571 <span class=\"match\">percent</span>, or 1.8818 <span class=\"match\">percent</span>. \n Next, we add the payroll adjustment (3.0758 <span class=\"match\">percent</span>) to the non-payroll adjustment (1.8818 <span class=\"match\">percent</span>), for a total inflation adjustment of 4.9576 <span class=\"match\">percent</span> (rounded) for FY 2026. \n Pursuant to the statute, the FY 2026 base revenue of $36,467,438 is increased by the total inflation adjustment of 4.9576 <span class=\"match\">percent</span>, yielding an inflation adjusted"},{"title":"Exercise of Time-Limited Authority To Increase the Fiscal Year 2026 Numerical Limitation for the H-2B Temporary Nonagricultural Worker Program","type":"Rule","abstract":"The Secretary of Homeland Security, in consultation with the Secretary of Labor, is exercising time-limited Fiscal Year (FY) 2026 authority to issue up to, but not more than, an additional 64,716 visas for the fiscal year. All of these supplemental visas will be available only to those American businesses that are suffering or will suffer impending irreparable harm, i.e., those facing permanent and severe financial loss, as attested by the employer. These supplemental visas will be distributed in three allocations based on the petitioner's start date of need through the end of the fiscal year.","document_number":"2026-02131","html_url":"https://www.federalregister.gov/documents/2026/02/03/2026-02131/exercise-of-time-limited-authority-to-increase-the-fiscal-year-2026-numerical-limitation-for-the","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-03/pdf/2026-02131.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-02131.pdf?1769807723","publication_date":"2026-02-03","agencies":[{"raw_name":"DEPARTMENT OF HOMELAND SECURITY","name":"Homeland Security Department","id":227,"url":"https://www.federalregister.gov/agencies/homeland-security-department","json_url":"https://www.federalregister.gov/api/v1/agencies/227","parent_id":null,"slug":"homeland-security-department"},{"raw_name":"DEPARTMENT OF LABOR","name":"Labor Department","id":271,"url":"https://www.federalregister.gov/agencies/labor-department","json_url":"https://www.federalregister.gov/api/v1/agencies/271","parent_id":null,"slug":"labor-department"},{"raw_name":"Employment and Training Administration","name":"Employment and Training Administration","id":133,"url":"https://www.federalregister.gov/agencies/employment-and-training-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/133","parent_id":271,"slug":"employment-and-training-administration"}],"excerpts":"the first half of a <span class=\"match\">fiscal</span> year, and the remaining annual allocation, <span class=\"match\">including</span> any unused nonimmigrant H-2B visas from the first half of a <span class=\"match\">fiscal</span> year, will be available for employers seeking to hire H-2B workers during the second half of the <span class=\"match\">fiscal</span> year.\n 3 \n \n If the full statutory cap of H-2B visas are not utilized in a given <span class=\"match\">fiscal</span> year, DHS cannot carry over the unused numbers for petition approvals for employment start dates beginning on or after the start of the next <span class=\"match\">fiscal</span> year.\n \n \n \n 3 \n  The Federal Government's <span class=\"match\">fiscal</span> year runs from October"},{"title":"Biosimilar User Fee Rates for Fiscal Year 2026","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the rates for biosimilar user fees for fiscal year (FY) 2026. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Biosimilar User Fee Amendments of 2022 (BsUFA III), authorizes FDA to assess and collect user fees for certain activities in connection with biosimilar biological product development; review of certain applications for approval of biosimilar biological products; and each biosimilar biological product approved in a biosimilar biological product application. BsUFA III directs FDA to establish, before the beginning of each fiscal year, the amount of initial and annual biosimilar biological product development (BPD) fees, the reactivation fee, and the biosimilar biological product application and program fees for such year.","document_number":"2025-14416","html_url":"https://www.federalregister.gov/documents/2025/07/30/2025-14416/biosimilar-user-fee-rates-for-fiscal-year-2026","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-30/pdf/2025-14416.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14416.pdf?1753793115","publication_date":"2025-07-30","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":" Annual <span class=\"match\">Percent</span> Change \n 6.6212% \n 3.1069% \n 3.2324% \n 4.3202% \n \n \n The statute specifies that this 4.3202 <span class=\"match\">percent</span> be multiplied by the proportion of all costs other than PC&amp;B to total costs of the process for the review of biosimilar biological product applications obligated. Since 54.5437 <span class=\"match\">percent</span> was obligated for PC&amp;B (as shown in table 2), 45.4563 <span class=\"match\">percent</span> is the portion of costs other than PC&amp;B (100 <span class=\"match\">percent</span> minus 54.5437 <span class=\"match\">percent</span> equals 45.4563 <span class=\"match\">percent</span>). The non-payroll adjustment is 4.3202 <span class=\"match\">percent</span> times 45.4563 <span class=\"match\">percent</span>, 1.9638 percent"},{"title":"Prescription Drug User Fee Rates for Fiscal Year 2026","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the rates for prescription drug user fees for fiscal year (FY) 2026. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Prescription Drug User Fee Amendments of 2022 (PDUFA VII), authorizes FDA to collect application fees for certain applications for the review of human drug and biological products and prescription drug program fees for certain approved products. This notice establishes the fee rates for FY 2026.","document_number":"2025-14413","html_url":"https://www.federalregister.gov/documents/2025/07/30/2025-14413/prescription-drug-user-fee-rates-for-fiscal-year-2026","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-30/pdf/2025-14413.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14413.pdf?1753793115","publication_date":"2025-07-30","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"4.3202 <span class=\"match\">percent</span> be multiplied by the proportion of all costs other than PC&amp;B to total costs of the process for the review of human drug applications obligated. Because 62.9725 <span class=\"match\">percent</span> was obligated for PC&amp;B (as shown in table 2), 37.0275 <span class=\"match\">percent</span> is the portion of costs other than PC&amp;B (100 <span class=\"match\">percent</span> minus 62.9725 <span class=\"match\">percent</span> equals 37.0275 <span class=\"match\">percent</span>). The non-payroll adjustment is 4.3202 <span class=\"match\">percent</span> times 37.0275 <span class=\"match\">percent</span>, or 1.5997 <span class=\"match\">percent</span>. \n Next, we add the payroll adjustment (3.4316 <span class=\"match\">percent</span>) to the non-payroll adjustment (1.5997 <span class=\"match\">percent</span>), for a"},{"title":"Over-the-Counter Monograph Drug User Fee Amendments-OTC Monograph Order Request Fee Rates for Fiscal Year 2026","type":"Notice","abstract":"The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Over-the-Counter Monograph Drug User Fee Amendments (herein referred to as \"OMUFA II\"), authorizes the Food and Drug Administration (FDA, the Agency, or we) to assess and collect user fees from qualifying manufacturers of over-the-counter (OTC) monograph drugs and submitters of OTC monograph order requests (OMOR)s for fiscal years 2026 through 2030. In this notice, FDA is announcing the OMOR fee rates for fiscal year (FY) 2026. FDA plans to announce the FY 2026 OMUFA facility fee rates, i.e., monograph drug facility (MDF) and contract manufacturing organization (CMO) facility fee rates, in a subsequent Federal Register notice (and anticipates its issuance will generally align with the timing of the OMUFA facility fee rate publication for prior FYs).","document_number":"2025-23852","html_url":"https://www.federalregister.gov/documents/2025/12/29/2025-23852/over-the-counter-monograph-drug-user-fee-amendments-otc-monograph-order-request-fee-rates-for-fiscal","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-12-29/pdf/2025-23852.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-23852.pdf?1766497516","publication_date":"2025-12-29","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"shown in table 2), 43.5571 <span class=\"match\">percent</span> is the portion of costs other than PC&amp;B (100 <span class=\"match\">percent</span>−56.4429 <span class=\"match\">percent</span> = 43.5571 <span class=\"match\">percent</span>). The non-payroll adjustment is 4.3202 <span class=\"match\">percent</span> × 43.5571 <span class=\"match\">percent</span>, or 1.8818 <span class=\"match\">percent</span>. \n Next, we add the payroll adjustment (3.0758 <span class=\"match\">percent</span>) to the non-payroll adjustment (1.8818 <span class=\"match\">percent</span>), for a total inflation adjustment of 4.9576 <span class=\"match\">percent</span> (rounded) for FY 2026. \n IV. OMOR Fee Calculations \n Under section 744M(a)(2)(A) of the FD&amp;C Act, each person that submits a qualifying OMOR shall be subject to a fee for an OMOR. The amount"},{"title":"Hiring Authority for College Graduates","type":"Rule","abstract":"The Office of Personnel Management (OPM) is issuing a final rule to amend its career and career-conditional employment regulations. The revision is necessary to implement the John S. McCain National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2019. This statute requires OPM to issue regulations establishing a hiring authority for college graduates into positions at specified grades in the competitive service. The intended effect of the authority is to provide additional flexibility in hiring eligible and qualified individuals.","document_number":"2026-03354","html_url":"https://www.federalregister.gov/documents/2026/02/20/2026-03354/hiring-authority-for-college-graduates","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-20/pdf/2026-03354.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-03354.pdf?1771508712","publication_date":"2026-02-20","agencies":[{"raw_name":"OFFICE OF PERSONNEL MANAGEMENT","name":"Personnel Management Office","id":406,"url":"https://www.federalregister.gov/agencies/personnel-management-office","json_url":"https://www.federalregister.gov/api/v1/agencies/406","parent_id":null,"slug":"personnel-management-office"}],"excerpts":"service of at least four years. \n Regarding the types of <span class=\"match\">positions</span> filled, the statute allows the authority to be used for professional and administrative <span class=\"match\">positions</span>. The statute did not include a specific definition of this term. At first, OPM considered <span class=\"match\">including</span> a specific definition with a list of specific occupations. However, we believe that OPM classification standards and other guidance on classifying <span class=\"match\">positions</span> provide ample information to allow agencies to designate the types of <span class=\"match\">positions</span> that are professional or administrative. This approach"},{"title":"Hiring Authority for Post-Secondary Students","type":"Rule","abstract":"The Office of Personnel Management (OPM) is issuing a final rule to amend its career and career-conditional employment regulations. The revision is necessary to implement section 1108 of the John S. McCain National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2019, which requires OPM to issue regulations implementing hiring authorities that allow agencies to hire certain post-secondary students into positions at specified grades in the competitive service. The intended effect of the authority is to provide additional flexibility in hiring eligible and qualified individuals.","document_number":"2026-03242","html_url":"https://www.federalregister.gov/documents/2026/02/19/2026-03242/hiring-authority-for-post-secondary-students","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-19/pdf/2026-03242.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-03242.pdf?1771422312","publication_date":"2026-02-19","agencies":[{"raw_name":"OFFICE OF PERSONNEL MANAGEMENT","name":"Personnel Management Office","id":406,"url":"https://www.federalregister.gov/agencies/personnel-management-office","json_url":"https://www.federalregister.gov/api/v1/agencies/406","parent_id":null,"slug":"personnel-management-office"}],"excerpts":"not incorporating a requirement for a nexus between the student's academic study and the <span class=\"match\">position</span> being filled. \n Classification of <span class=\"match\">Positions</span> \n Two commenters requested information on whether the <span class=\"match\">position</span> descriptions used for Pathways Internship <span class=\"match\">positions</span> may be used for <span class=\"match\">positions</span> filled under this authority. An agency may use similar <span class=\"match\">position</span> descriptions for Pathways Intern <span class=\"match\">positions</span> for Post-Secondary Student <span class=\"match\">positions</span>. However, an independent <span class=\"match\">position</span> description may need to be established as required by an agency's classification policy. "},{"title":"Generic Drug User Fee Rates for Fiscal Year 2026","type":"Notice","abstract":"The Federal Food, Drug, and Cosmetic Act (FD&C Act or statute), as amended by the Generic Drug User Fee Amendments of 2022 (GDUFA III), authorizes the Food and Drug Administration (FDA, Agency, or we) to assess and collect fees for abbreviated new drug applications (ANDAs); drug master files (DMFs); generic drug active pharmaceutical ingredient (API) facilities, finished dosage form (FDF) facilities, and contract manufacturing organization (CMO) facilities; and generic drug applicant program user fees. In this document, FDA is announcing fiscal year (FY) 2026 rates for GDUFA III fees.","document_number":"2025-14411","html_url":"https://www.federalregister.gov/documents/2025/07/30/2025-14411/generic-drug-user-fee-rates-for-fiscal-year-2026","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-30/pdf/2025-14411.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14411.pdf?1753793114","publication_date":"2025-07-30","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"specified <span class=\"match\">fiscal</span> years and provides the <span class=\"match\">percent</span> change from the previous <span class=\"match\">fiscal</span> year and the average <span class=\"match\">percent</span> change over the first 3 of the 4 <span class=\"match\">fiscal</span> years preceding FY 2026. The 3-year average is 5.4494 <span class=\"match\">percent</span>. \n \n Table 2—FDA Personnel Compensation and Benefits (PC&amp;B) Each Year and <span class=\"match\">Percent</span> Change \n \n <span class=\"match\">Fiscal</span> year \n 2022 \n 2023 \n 2024 \n 3-Year average \n \n \n Total PC&amp;B \n $3,165,477,000 \n $3,436,513,000 \n $3,791,729,000 \n \n \n \n Total FTEs \n 18,474 \n 18,729 \n 19,687 \n \n \n \n PC&amp;B per FTE \n $171,348 \n $183,486 \n $192,601 \n \n \n \n <span class=\"match\">Percent</span> Change"},{"title":"Animal Drug User Fee Rates and Payment Procedures for Fiscal Year 2026","type":"Notice","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the fee rates and payment procedures for fiscal year (FY) 2026 animal drug user fees. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Animal Drug User Fee Amendments of 2023 (ADUFA V), authorizes FDA to collect user fees for certain animal drug applications and supplemental animal drug applications, for certain animal drug products, for certain establishments where such products are made, and for certain sponsors of such animal drug applications and/or investigational animal drug submissions. This notice establishes the fee rates for FY 2026.","document_number":"2025-14417","html_url":"https://www.federalregister.gov/documents/2025/07/30/2025-14417/animal-drug-user-fee-rates-and-payment-procedures-for-fiscal-year-2026","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-30/pdf/2025-14417.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14417.pdf?1753793115","publication_date":"2025-07-30","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"PC&amp;B (100 <span class=\"match\">percent</span> minus the PC&amp;B percentage of 52.2090). The portion of the inflation adjustment relating to non-payroll costs is 4.1709 <span class=\"match\">percent</span> multiplied by 47.7910 <span class=\"match\">percent</span>, or 1.9933 <span class=\"match\">percent</span>. \n Next, we add the payroll component (2.8451percent) to the non-payroll component (1.9933 <span class=\"match\">percent</span>), for an inflation adjustment of 4.8384 <span class=\"match\">percent</span> for FY 2026. \n Section 740(c)(2)(B) of the FD&amp;C Act provides for the inflation adjustment to be compounded each <span class=\"match\">fiscal</span> year after FY 2025. The inflation adjustment for FY 2026 (4.8384 <span class=\"match\">percent</span>) is compounded"},{"title":"Review of the Commission's Assessment and Collection of Regulatory Fees for Fiscal Year 2025","type":"Rule","abstract":"In this document, the Federal Communications Commission (Commission or FCC) adopts its regulatory fee schedule to assess and collect regulatory fees for Fiscal Year 2025 (FY 25).","document_number":"2025-17218","html_url":"https://www.federalregister.gov/documents/2025/09/08/2025-17218/review-of-the-commissions-assessment-and-collection-of-regulatory-fees-for-fiscal-year-2025","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-09-08/pdf/2025-17218.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-17218.pdf?1757076324","publication_date":"2025-09-08","agencies":[{"raw_name":"FEDERAL COMMUNICATIONS COMMISSION","name":"Federal Communications Commission","id":161,"url":"https://www.federalregister.gov/agencies/federal-communications-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/161","parent_id":null,"slug":"federal-communications-commission"}],"excerpts":"total amount the Commission must collect in an offsetting collection generally changes each <span class=\"match\">fiscal</span> year, and payors' regulatory fees will also typically change each <span class=\"match\">fiscal</span> year as a mathematical consequence of the changes in the total amount to be collected, the number of full-time equivalents (FTEs), and projected unit estimates for each regulatory fee category.\n \n In the FY 2025 NPRM, the Commission sought comment on several regulatory fee issues, <span class=\"match\">including</span>: (i) the proposed regulatory fees and methodology for FY 2025, as set forth in Tables 2, 3"},{"title":"Medical Device User Fee Rates for Fiscal Year 2026","type":"Notice","abstract":"The Food and Drug Administration (FDA) is announcing the fee rates and payment procedures for medical device user fees for fiscal year (FY) 2026. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Medical Device User Fee Amendments of 2022 (MDUFA V), authorizes FDA to collect user fees for certain medical device submissions and annual fees both for certain periodic reports and for establishments subject to registration. This notice establishes the fee rates for FY 2026, which apply from October 1, 2025, through September 30, 2026, and provides information on how the fees for FY 2026 were determined, the payment procedures you should follow, and how you may qualify for reduced small business fees.","document_number":"2025-14412","html_url":"https://www.federalregister.gov/documents/2025/07/30/2025-14412/medical-device-user-fee-rates-for-fiscal-year-2026","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-30/pdf/2025-14412.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14412.pdf?1753793115","publication_date":"2025-07-30","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"3-Year Average <span class=\"match\">Percent</span> Change in Washington-Arlington-Alexandria Area CPI \n \n   \n 2022 \n 2023 \n 2024 \n 3-year average \n \n \n Annual CPI \n 296.117 \n 305.317 \n 315.186 \n \n \n \n Annual <span class=\"match\">Percent</span> Change \n 6.6212% \n 3.1069% \n 3.2324% \n \n \n \n 3-Year Average <span class=\"match\">Percent</span> Change in CPI \n \n \n \n 4.3202% \n \n \n The non-payroll adjustment is 4.3202 <span class=\"match\">percent</span> multiplied by 40 <span class=\"match\">percent</span>, or 1.7281 <span class=\"match\">percent</span>. Next, the payroll adjustment (3.2696 <span class=\"match\">percent</span> or 0.032696) is added to the non-payroll adjustment (1.7281 <span class=\"match\">percent</span> or 0.017281), for a total of 4.9977 <span class=\"match\">percent</span> (or 0.049977)"},{"title":"Animal Generic Drug User Fee Program Rates and Payment Procedures for Fiscal Year 2026","type":"Notice","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the fee rates and payment procedures for fiscal year (FY) 2026 generic new animal drug program user fees. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Animal Generic Drug User Fee Amendments of 2023 (AGDUFA IV), authorizes FDA to collect user fees for certain abbreviated applications for generic new animal drugs, for certain generic new animal drug products, for certain sponsors of such abbreviated applications for generic new animal drugs and/or investigational submissions for generic new animal drugs (JINADs), and for certain submissions related to JINAD files. This notice establishes the fee rates for FY 2026.","document_number":"2025-14409","html_url":"https://www.federalregister.gov/documents/2025/07/30/2025-14409/animal-generic-drug-user-fee-program-rates-and-payment-procedures-for-fiscal-year-2026","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-30/pdf/2025-14409.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14409.pdf?1753793114","publication_date":"2025-07-30","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"portion of the inflation adjustment relating to non-payroll costs is 4.1709 <span class=\"match\">percent</span> multiplied by 47.7910 <span class=\"match\">percent</span>, or 1.9933 <span class=\"match\">percent</span>. \n Next, we add the payroll component (2.8451 <span class=\"match\">percent</span>) to the non-payroll component (1.9933 <span class=\"match\">percent</span>), for an inflation adjustment of 4.8384 <span class=\"match\">percent</span> for FY 2026. \n Section 741(c)(2)(B) of the FD&amp;C Act provides for the inflation adjustment to be compounded each <span class=\"match\">fiscal</span> year after FY 2025. The inflation adjustment for FY 2026 (4.8384 <span class=\"match\">percent</span>) is compounded by adding 1 and then multiplying by 1 plus the inflation adjustment"},{"title":"Over-the-Counter Monograph Drug User Fee Program-Facility Fee Rates for Fiscal Year 2025","type":"Notice","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the over-the-counter (OTC) monograph drug facility (MDF) fee rates under the OTC monograph drug user fee program (OMUFA) for fiscal year (FY) 2025. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to assess and collect user fees from qualifying manufacturers of OTC monograph drugs and submitters of OTC monograph order requests (OMORs). This notice publishes the OMUFA facility fee rates for FY 2025.","document_number":"2025-04860","html_url":"https://www.federalregister.gov/documents/2025/03/21/2025-04860/over-the-counter-monograph-drug-user-fee-program-facility-fee-rates-for-fiscal-year-2025","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-03-21/pdf/2025-04860.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-04860.pdf?1742474715","publication_date":"2025-03-21","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"shown in table 2), 41.8738 <span class=\"match\">percent</span> is the portion of costs other than PC&amp;B (100 <span class=\"match\">percent</span> minus 58.1262 <span class=\"match\">percent</span> equals 41.8738 <span class=\"match\">percent</span>). The nonpayroll adjustment is 4.5616 <span class=\"match\">percent</span> times 41.8738 <span class=\"match\">percent</span>, or 1.9101 <span class=\"match\">percent</span>. \n Next, we add the payroll adjustment (2.2401 <span class=\"match\">percent</span>) to the nonpayroll adjustment (1.9101 <span class=\"match\">percent</span>), for a total inflation adjustment of 4.1502 <span class=\"match\">percent</span> (rounded) for FY 2025. \n Pursuant to the statute, the FY 2025 base revenue of $29,253,365 is increased by the total inflation adjustment of 4.1502 <span class=\"match\">percent</span>, yielding an inflation"},{"title":"Technical Assistance on State Data Collection-National Technical Assistance Center To Improve State Capacity To Collect, Report, Analyze, and Use Accurate IDEA Part B and Part C Fiscal Data","type":"Proposed Rule","abstract":"The Department of Education (Department) proposes a priority for a National Technical Assistance Center to Improve State Capacity to Collect, Report, Analyze, and Use Accurate IDEA Part B and Part C Fiscal Data Center (Fiscal Data Center) under the Technical Assistance on State Data Collection program. The Department may use this priority for competitions in fiscal year (FY) 2025 and later years. We take this action to focus attention on an identified national need to provide technical assistance (TA) to improve the capacity of States to meet the fiscal data collection requirements under Part B and Part C of the Individuals with Disabilities Education Act (IDEA). This Fiscal Data Center will support States in collecting, reporting, and determining how to best analyze and use their IDEA Part B and Part C fiscal data to establish and meet high expectations for each child with a disability and will customize its TA to meet each State's specific needs.","document_number":"2025-00985","html_url":"https://www.federalregister.gov/documents/2025/01/21/2025-00985/technical-assistance-on-state-data-collection-national-technical-assistance-center-to-improve-state","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-01-21/pdf/2025-00985.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-00985.pdf?1737121514","publication_date":"2025-01-21","agencies":[{"raw_name":"DEPARTMENT OF EDUCATION","name":"Education Department","id":126,"url":"https://www.federalregister.gov/agencies/education-department","json_url":"https://www.federalregister.gov/api/v1/agencies/126","parent_id":null,"slug":"education-department"}],"excerpts":"accurately collect, report, analyze, and use <span class=\"match\">fiscal</span> data. In 2023, 23 <span class=\"match\">percent</span> of State Directors of Special Education, who are responsible for implementing IDEA Part B requirements <span class=\"match\">including</span> <span class=\"match\">fiscal</span> requirements, left their <span class=\"match\">positions</span>, and 38 <span class=\"match\">percent</span> of State Directors of Special Education had fewer than two years of experience in their roles that year.\n 3 \n \n Similar leadership trends can be found in Part C LAs. In 2023, 49 <span class=\"match\">percent</span> of Part C Coordinators, who are responsible for implementing IDEA Part C, <span class=\"match\">including</span> <span class=\"match\">fiscal</span> requirements and providing information"},{"title":"Science and Technology Reinvention Laboratory Personnel Demonstration Project Program","type":"Notice","abstract":"STRLs will implement Senior Business Technical Manager (SBTM) positions, which are defined as senior business and technical positions comparable to positions classified above the General Schedule (GS)-15 level. SBTMs are senior business and operations leaders within the STRL, serving as primary advisors to the STRL's Commanding Officers and/or members of the Senior Executive Service (SES). SBTMs oversee and operationalize the STRL's business operations, administration, and technology functions. SBTM positions may only be established at authorized STRLs with personnel demonstration projects.","document_number":"2026-00277","html_url":"https://www.federalregister.gov/documents/2026/01/09/2026-00277/science-and-technology-reinvention-laboratory-personnel-demonstration-project-program","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-01-09/pdf/2026-00277.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-00277.pdf?1767879915","publication_date":"2026-01-09","agencies":[{"raw_name":"DEPARTMENT OF DEFENSE","name":"Defense Department","id":103,"url":"https://www.federalregister.gov/agencies/defense-department","json_url":"https://www.federalregister.gov/api/v1/agencies/103","parent_id":null,"slug":"defense-department"},{"raw_name":"Office of the Secretary"}],"excerpts":"SBTM <span class=\"match\">Positions</span> \n 1. Authorized <span class=\"match\">Positions</span> \n The number of authorized SBTM <span class=\"match\">positions</span> in each STRL shall not exceed one <span class=\"match\">percent</span> of the number of civilian and military <span class=\"match\">positions</span> employed at such laboratory, inclusive of <span class=\"match\">positions</span> both within and outside the STRL's personnel demonstration project, which are filled as of the close of the preceding <span class=\"match\">fiscal</span> year. If one <span class=\"match\">percent</span> of authorized <span class=\"match\">positions</span> does not equate to a whole number, the STRL shall round down to the next lower number; however, each STRL shall be authorized at least one SBTM <span class=\"match\">position</span> regardless"},{"title":"Setting and Adjusting Trademark Fees During Fiscal Year 2025","type":"Rule","abstract":"The United States Patent and Trademark Office (USPTO) sets or adjusts trademark fees, as authorized by the Leahy-Smith America Invents Act (AIA), as amended by the Study of Underrepresented Classes Chasing Engineering and Science Success Act of 2018 (SUCCESS Act). The fee adjustments will provide the USPTO sufficient aggregate revenue to recover the aggregate costs of trademark operations in future years (based on assumptions and estimates found in the agency's Fiscal Year 2025 Congressional Justification (FY 2025 Budget)), including implementing the USPTO 2022-2026 Strategic Plan (Strategic Plan).","document_number":"2024-26644","html_url":"https://www.federalregister.gov/documents/2024/11/18/2024-26644/setting-and-adjusting-trademark-fees-during-fiscal-year-2025","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-11-18/pdf/2024-26644.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-26644.pdf?1731678322","publication_date":"2024-11-18","agencies":[{"raw_name":"DEPARTMENT OF COMMERCE","name":"Commerce Department","id":54,"url":"https://www.federalregister.gov/agencies/commerce-department","json_url":"https://www.federalregister.gov/api/v1/agencies/54","parent_id":null,"slug":"commerce-department"},{"raw_name":"Patent and Trademark Office","name":"Patent and Trademark Office","id":402,"url":"https://www.federalregister.gov/agencies/patent-and-trademark-office","json_url":"https://www.federalregister.gov/api/v1/agencies/402","parent_id":54,"slug":"patent-and-trademark-office"}],"excerpts":"aggregate trademark fee revenue on the number of trademark applications and other fee-related filings it expects for a given <span class=\"match\">fiscal</span> year, work it expects to process in a given <span class=\"match\">fiscal</span> year (an indicator of fees paid after the agency performs work, such as SOU fees), expected examination and process requests in a given <span class=\"match\">fiscal</span> year, and the expected number of post-grant decisions to maintain trademark protection in a given <span class=\"match\">fiscal</span> year. Within its iterative process for estimating aggregate revenue, the USPTO adjusts individual fee rates up or down based"},{"title":"Notice of Funding Opportunity for the Rural Community Development Initiative (RCDI) for Fiscal Year 2025","type":"Notice","abstract":"The Rural Housing Service (RHS or the Agency), a Rural Development (RD) agency of the United States Department of Agriculture (USDA), announces the acceptance of applications under the Rural Community Development Initiative (RCDI) program for fiscal year (FY) 2025. Approximately $5 million in funding is available for FY 2025. These grants will be made to qualified Intermediary organizations that will provide financial and Technical assistance to Recipients to develop their capacity and ability to undertake projects related to housing, community facilities, or community and economic development that will support the community. Applicants are responsible for any expenses incurred in developing their applications.","document_number":"2025-12632","html_url":"https://www.federalregister.gov/documents/2025/07/08/2025-12632/notice-of-funding-opportunity-for-the-rural-community-development-initiative-rcdi-for-fiscal-year","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-08/pdf/2025-12632.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-12632.pdf?1751892312","publication_date":"2025-07-08","agencies":[{"raw_name":"DEPARTMENT OF AGRICULTURE","name":"Agriculture Department","id":12,"url":"https://www.federalregister.gov/agencies/agriculture-department","json_url":"https://www.federalregister.gov/api/v1/agencies/12","parent_id":null,"slug":"agriculture-department"},{"raw_name":"Rural Housing Service","name":"Rural Housing Service","id":458,"url":"https://www.federalregister.gov/agencies/rural-housing-service","json_url":"https://www.federalregister.gov/api/v1/agencies/458","parent_id":12,"slug":"rural-housing-service"}],"excerpts":"nonprofit organization (<span class=\"match\">including</span> faith-based and community organizations and philanthropic organizations), or public (<span class=\"match\">including</span> Tribal) organization that provides financial and Technical assistance to multiple Recipients.\n \n \n Low-income rural community. \n An authority, district, economic development authority, regional council, Federally recognized Tribe, or unit of government representing an incorporated city, town, village, county, township, parish, Indian reservation or borough whose income is at or below 80 <span class=\"match\">percent</span> of either the state or national"},{"title":"Biosimilar User Fee Rates for Fiscal Year 2025","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the rates for biosimilar user fees for fiscal year (FY) 2025. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Biosimilar User Fee Amendments of 2022 (BsUFA III), authorizes FDA to assess and collect user fees for certain activities in connection with biosimilar biological product development; review of certain applications for approval of biosimilar biological products; and each biosimilar biological product approved in a biosimilar biological product application. BsUFA III directs FDA to establish, before the beginning of each fiscal year, the amount of initial and annual biosimilar biological product development (BPD) fees, the reactivation fee, and the biosimilar biological product application and program fees for such year. These fees apply to the period from October 1, 2024, through September 30, 2025.","document_number":"2024-16884","html_url":"https://www.federalregister.gov/documents/2024/07/31/2024-16884/biosimilar-user-fee-rates-for-fiscal-year-2025","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-07-31/pdf/2024-16884.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-16884.pdf?1722343537","publication_date":"2024-07-31","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":" Annual <span class=\"match\">Percent</span> Change \n 3.9568% \n 6.6212% \n 3.1069% \n 4.5616% \n \n \n The statute specifies that this 4.5616 <span class=\"match\">percent</span> be multiplied by the proportion of all costs other than PC&amp;B to total costs of the process for the review of biosimilar biological product applications obligated. Since 52.7749 <span class=\"match\">percent</span> was obligated for PC&amp;B (as shown in table 2), 47.2251 <span class=\"match\">percent</span> is the portion of costs other than PC&amp;B (100 <span class=\"match\">percent</span> minus 52.7749 <span class=\"match\">percent</span> equals 47.2251 <span class=\"match\">percent</span>). The non-payroll adjustment is 4.5616 <span class=\"match\">percent</span> times 47.2251 <span class=\"match\">percent</span>, 2.1542 percent"},{"title":"Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program","type":"Proposed Rule","abstract":"This proposed rule would update the prospective payment rates for inpatient rehabilitation facilities (IRFs) for Federal fiscal year (FY) 2027. As required by statute, this proposed rule includes the classification and weighting factors for the IRF prospective payment system's case-mix groups and a description of the methodologies and data used in computing the prospective payment rates for FY 2027. It also continues the third year of the 3-year phaseout of the rural adjustment, which began in FY 2025. This proposed rule includes a solicitation for public comments on alternative data sources for the IRF PPS wage index; proposes to require all therapy treatments or therapy evaluations to begin within 36-hours from midnight on the day of admission; proposes to require a patient's current functional status be documented on the preadmission screening; proposes requirements for the initial Interdisciplinary Team meeting; and includes a request for information on potential future IRF PPS payment reform. Additionally, the proposed rule includes updates to the IRF Quality Reporting Program. Furthermore, the proposed rule includes changes to the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies Competitive Bidding Program.","document_number":"2026-06642","html_url":"https://www.federalregister.gov/documents/2026/04/06/2026-06642/medicare-program-inpatient-rehabilitation-facility-prospective-payment-system-for-federal-fiscal","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-06/pdf/2026-06642.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-06642.pdf?1775160907","publication_date":"2026-04-06","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"teaching status, <span class=\"match\">including</span> non-teaching IRFs, IRFs with an intern and resident to average daily census (ADC) ratio less than 10 <span class=\"match\">percent</span>, IRFs with an intern and resident to ADC ratio greater than or equal to 10 <span class=\"match\">percent</span> and less than or equal to 19 <span class=\"match\">percent</span>, and IRFs with an intern and resident to ADC ratio greater than 19 <span class=\"match\">percent</span>. Finally, IRFs are grouped by DSH PP, <span class=\"match\">including</span> IRFs with zero DSH PP, IRFs with a DSH PP less than 5 <span class=\"match\">percent</span>, IRFs with a DSH PP between 5 and less than 10 <span class=\"match\">percent</span>, IRFs with a DSH PP between 10 and 20 <span class=\"match\">percent</span>, and IRFs with"},{"title":"Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2026 and Updates to the IRF Quality Reporting Program","type":"Rule","abstract":"This final rule updates the prospective payment rates for inpatient rehabilitation facilities (IRFs) for Federal fiscal year (FY) 2026. As required by statute, this final rule includes the classification and weighting factors for the IRF prospective payment system's case-mix groups and a description of the methodologies and data used in computing the prospective payment rates for FY 2026. It also continues the second year of the 3-year phaseout of the rural adjustment, which began in FY 2025. Additionally, the final rule includes updates to the IRF Quality Reporting Program.","document_number":"2025-14780","html_url":"https://www.federalregister.gov/documents/2025/08/05/2025-14780/medicare-program-inpatient-rehabilitation-facility-prospective-payment-system-for-federal-fiscal","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-08-05/pdf/2025-14780.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14780.pdf?1754079306","publication_date":"2025-08-05","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"teaching status, <span class=\"match\">including</span> non-teaching IRFs, IRFs with an intern and resident to average daily census (ADC) ratio less than 10 <span class=\"match\">percent</span>, IRFs with an intern and resident to ADC ratio greater than or equal to 10 <span class=\"match\">percent</span> and less than or equal to 19 <span class=\"match\">percent</span>, and IRFs with an intern and resident to ADC ratio greater than 19 <span class=\"match\">percent</span>. Finally, IRFs are grouped by DSH PP, <span class=\"match\">including</span> IRFs with zero DSH PP, IRFs with a DSH PP less than 5 <span class=\"match\">percent</span>, IRFs with a DSH PP between 5 and less than 10 \n \n <span class=\"match\">percent</span>, IRFs with a DSH PP between 10 and 20 <span class=\"match\">percent</span>, and IRFs with"}]}